Billionaires have leaned hard into biotech investments in recent years, backing small and large companies alike. Andrew “Twiggy” Forrest has joined… Read more
The resources used by biotech labs often lag behind the new technological advances available to them. Digitalization, automation, robotics, and more… Read more
Digital health solutions have expanded access to care for millions, but not all groups have gotten the benefits of these technologies. In a new AJMC… Read more
Last Wednesday, July 27th, Bristol Meyer Squibb’s CEO Giovanni Caforio signaled that the company has the resources to grow its holdings and it intends… Read more
Moderna has signed a contract worth up to $1.74 billion with the US government to provide an updated version of its mRNA vaccine. This version of the… Read more
New research published in the Annals of Internal Medicine suggests the price tag on Sanofi and Regeneron's cholesterol-lowering drug, Praluent, is not… Read more
President Donald Trump is still looking to keep the pressure on pharmaceutical companies in an effort to keep U.S. drug prices down, but some… Read more
Although payer decision-making has been a key use of real-world evidence (RWE) and real-world data (RWD) in the healthcare space, there are far more… Read more
Despite a litany of complaints and concerns from the industry, the new US drug pricing reform passed by the Democrats would have a marginal impact on… Read more
Taking on a more holistic approach to care requires consideration of a patient’s social determinants of health (SDoH). Amongst these factors is… Read more